HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard J H Smith Selected Research

Connexin 26

8/2012The spectrum of GJB2 mutations in the Iranian population with non-syndromic hearing loss--a twelve year study.
2/2012Spectrum of GJB2 (Cx26) gene mutations in Iranian Azeri patients with nonsyndromic autosomal recessive hearing loss.
7/2011Viral vector tropism for supporting cells in the developing murine cochlea.
5/2011Two Iranian families with a novel mutation in GJB2 causing autosomal dominant nonsyndromic hearing loss.
12/2005GJB2 mutations and degree of hearing loss: a multicenter study.
10/2004GJB2: the spectrum of deafness-causing allele variants and their phenotype.
12/2003GJB2 gene mutations causing familial hereditary deafness in Turkey.
8/2002Medical evaluation of pediatric hearing loss. Laboratory, radiographic, and genetic testing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard J H Smith Research Topics

Disease

43Hearing Loss (Hearing Impairment)
04/2022 - 05/2002
24Deafness (Deaf Mutism)
01/2022 - 05/2002
18Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2021 - 09/2007
16Atypical Hemolytic Uremic Syndrome
01/2022 - 02/2009
16Glomerulonephritis
09/2021 - 05/2010
16Nonsyndromic Deafness
05/2020 - 05/2002
8Otosclerosis
05/2012 - 09/2007
7Chronic Kidney Failure (Chronic Renal Failure)
09/2022 - 02/2011
6Recurrent respiratory papillomatosis
03/2022 - 11/2002
5Rare Diseases (Rare Disease)
10/2022 - 09/2007
5Inflammation (Inflammations)
10/2022 - 06/2008
5Proteinuria
09/2022 - 09/2007
4Renal Insufficiency (Renal Failure)
10/2022 - 05/2005
4Sensorineural Hearing Loss
01/2022 - 12/2010
4Paraproteinemias (Monoclonal Gammopathy)
09/2021 - 09/2013
3Infections
01/2022 - 06/2016
3Thrombocytopenia (Thrombopenia)
11/2020 - 02/2011
3Autosomal Dominant 5 Deafness
05/2020 - 08/2005
3Thrombotic Microangiopathies
01/2020 - 01/2014
3Male Infertility (Male Sterility)
01/2018 - 04/2009
324 Autosomal Recessive Deafness
03/2010 - 05/2007
2Pierre Robin Syndrome (Syndrome, Pierre Robin)
01/2021 - 03/2020
2Kidney Diseases (Kidney Disease)
01/2019 - 12/2017
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 09/2013
2Auditory neuropathy
08/2015 - 01/2008
2Inborn Genetic Diseases (Disease, Hereditary)
03/2014 - 08/2011
2Monoclonal Gammopathy of Undetermined Significance
09/2013 - 11/2010
2Disease Progression
05/2013 - 09/2005
2Pathologic Constriction (Stenosis)
05/2011 - 04/2004
2Usher Syndromes (Usher Syndrome)
08/2010 - 06/2009
2Papilloma (Papillomatosis)
04/2010 - 11/2002
2Pendred syndrome
06/2007 - 02/2002
2Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome)
04/2007 - 09/2004
2Carcinogenesis
01/2006 - 11/2005
1Asthma (Bronchial Asthma)
03/2022
1Respiratory Insufficiency (Respiratory Failure)
03/2022
1Nephrotic Syndrome (Syndrome, Nephrotic)
11/2020
1Bilateral Hearing Loss
11/2020
1Pre-Eclampsia (Preeclampsia)
11/2020
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
11/2020
1COVID-19
11/2020
1Airway Obstruction (Choking)
03/2020
1Arthritis (Polyarthritis)
01/2019

Drug/Important Bio-Agent (IBA)

33Complement System Proteins (Complement)IBA
10/2022 - 10/2004
15Proteins (Proteins, Gene)FDA Link
06/2021 - 11/2002
14Dichlorodiphenyldichloroethane (DDD)IBA
01/2019 - 09/2007
13DNA (Deoxyribonucleic Acid)IBA
12/2018 - 08/2003
8Connexin 26IBA
08/2012 - 08/2002
6Complement Factor H (Factor H)IBA
09/2021 - 05/2005
6Capsules (Microcapsules)IBA
05/2012 - 09/2007
5Antigen-Antibody Complex (Immune Complex)IBA
01/2021 - 05/2009
5Complement Factor B (Factor B)IBA
11/2020 - 05/2010
4NucleotidesIBA
12/2016 - 11/2005
4Immunoglobulins (Immunoglobulin)IBA
06/2016 - 05/2009
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2003
3Complement C3 (C3 Complement)IBA
01/2021 - 04/2015
3MicroRNAs (MicroRNA)IBA
01/2019 - 03/2010
3CreatinineIBA
01/2018 - 04/2016
3Mitochondrial DNA (mtDNA)IBA
05/2015 - 01/2006
3ConnexinsIBA
07/2011 - 12/2003
3Nonsense Codon (Nonsense Mutation)IBA
02/2011 - 02/2007
3cyclonite (RDX)IBA
03/2010 - 05/2007
2Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2015
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
10/2022 - 06/2015
2AminoglycosidesIBA
01/2022 - 06/2011
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2016 - 07/2012
2Rituximab (Mabthera)FDA Link
09/2013 - 09/2007
2Dexamethasone (Maxidex)FDA LinkGeneric
09/2013 - 12/2010
2Cidofovir (Vistide)FDA Link
04/2010 - 11/2005
2Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
09/2009 - 08/2009
2Fibrinogen (Factor I)FDA Link
02/2009 - 02/2009
2Transforming Growth Factor beta (TGF-beta)IBA
04/2008 - 09/2007
2Messenger RNA (mRNA)IBA
01/2007 - 11/2002
2CytosineIBA
01/2007 - 11/2005
2Myosins (Myosin)IBA
11/2005 - 05/2002
1Complement C3 Nephritic FactorIBA
10/2022
1pembrolizumabIBA
03/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
03/2022
116S Ribosomal RNAIBA
01/2022
1Immunoglobulin G (IgG)IBA
09/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1CytokinesIBA
11/2020
1Dihydrotachysterol (AT 10)IBA
11/2020
1A 7 (A-7)IBA
11/2020
1Apolipoprotein L1IBA
11/2020
1RNA (Ribonucleic Acid)IBA
12/2019
1Protein Isoforms (Isoforms)IBA
12/2019
1Antisense OligonucleotidesIBA
10/2019
1Pharmaceutical PreparationsIBA
10/2019

Therapy/Procedure

14Therapeutics
09/2022 - 10/2002
8Cochlear Implantation
01/2022 - 02/2002
6Cochlear Implants (Cochlear Implant)
01/2022 - 05/2002
3Transplantation
09/2022 - 02/2009
2Otoscopes
11/2020 - 05/2020
2Lasers (Laser)
01/2017 - 05/2011
1Complementary Therapies (Alternative Medicine)
01/2022
1Distraction Osteogenesis
01/2021
1Cesarean Section (Caesarean Section)
11/2020
1Injections
06/2020
1Airway Management
03/2020